TSS Named a Di Gasell 2025

A person wearing blue gloves and a lab coat is handling a large metal plate, partially immersing it into an industrial liquid tank in a laboratory.
We’re proud to share that TSS has been recognized as a Di Gasell 2025, an award from the national financial newspaper Dagens industri celebrating Sweden’s fastest-growing and most successful companies.

The Di Gasell recognition highlights companies that demonstrate strong, sustainable, and organic growth while maintaining financial stability and a solid business foundation. Each year, only a small percentage of Swedish companies meet the high standards required to become a Gasell.

“This milestone is a testament to our dedication, innovation, and teamwork at TSS. Every one of us has contributed to this achievement, from developing progressive solutions to supporting our customers. It truly shows what we can accomplish together,” says Tobias Holmer, CEO of TSS.

This recognition reflects the continued growth of TSS as a trusted partner in automated temperature monitoring and data-driven compliance for the life science supply chain. It also highlights the collective effort of our teams—driving innovation, delivering customer value, and ensuring product integrity at every stage of the supply chain.

Being named a Di Gasell is more than a financial achievement—it’s a recognition of resilience, collaboration, and purpose. At TSS, we’re proud to grow together with our customers and partners as we continue shaping the future of temperature monitoring.

You may also be interested in

Exploring the solution to a global question

When it comes to global transportation and shipping of drugs, simply knowing where they are is no longer enough. Pharmaceutical organisations are becoming increasingly aware of the safety regulations which go into storage and transportation, i.e. ensuring that every drug which reaches the patient end, is effective and safe for consumption.
Read moreDownload Whitepaper

Data-driven supply chains: improving your excursion rate and temperature performance in 5 steps

Data is an essential requirement for improving supply chain processes. But that doesn’t mean that simply collecting more of it will instantly lead to reductions in waste, increases in efficiency and lower excursion rates. Taking a more targeted approach will help you turn supply chain data into insights that can help you understand exactly what is happening at every stage of your pharmaceutical supply chain.
Read moreDownload Whitepaper

On-demand webinar: Digitalization and its impact on the pharma supply chain

Get introduced about how to implement digital efficiencies and inform the future of medical supply chains.
Read moreDownload Whitepaper

You may also be interested in

TSS Sponsors the 27th Annual Clinical Trial Supply Europe 2026 in Barcelona

TSS is proud to sponsor the 27th Annual Clinical Trial Supply Europe, taking place 24–25 February 2026 in Barcelona, Spain. The event brings together clinical supply professionals, sponsors, CROs, and solution providers to discuss how to strengthen resilience, quality, and patient safety across the clinical trial supply chain.
Read more

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.